ProPhase Labs, Inc. Net Income Loss

• ProPhase Labs, Inc. showed a decrease of -218.0% in Net Income Loss from 2023 to 2024.
• This data is from ProPhase Labs, Inc.'s annual report (Form 10-K), filed with the SEC on April 1, 2025.
• XBRL data for this metric is available from 2009 to 2024 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 16 years of available data (2009 to 2024), ProPhase Labs, Inc.'s Net Income Loss has declined by 1,289.0%.
• Historical annual values: Fiscal year 2024: -$53.36 million | Fiscal year 2023: -$16.78 million | Fiscal year 2022: $18.46 million | Fiscal year 2021: $6.27 million | Fiscal year 2020: -$2.13 million | Fiscal year 2019: -$3.15 million | Fiscal year 2018: -$1.74 million | Fiscal year 2017: $40.59 million | Fiscal year 2016: -$2.87 million | Fiscal year 2015: -$3.60 million | Fiscal year 2014: -$7.83 million | Fiscal year 2013: $405.0 thousand | Fiscal year 2012: -$1.09 million | Fiscal year 2011: -$2.71 million | Fiscal year 2010: -$3.50 million | Fiscal year 2009: -$3.84 million.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026